Construction of immunotherapy-related prognostic gene signature and small molecule drug prediction for cutaneous melanoma
BackgroundCutaneous melanoma (CM), a kind of skin cancer with a high rate of advanced mortality, exhibits a wide variety of driver and transmitter gene alterations in the immunological tumor microenvironment (TME) associated with tumor cell survival and proliferation.MethodsWe analyzed the immunolog...
Main Authors: | Jiahua Xing, Ziqi Jia, Yan Li, Yan Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.939385/full |
Similar Items
-
Prognostic Value and Immunological Characteristics of a Novel RNA Binding Protein Signature in Cutaneous Melanoma
by: Jun Tian, et al.
Published: (2021-08-01) -
Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma
by: Kefan Lin, et al.
Published: (2023-04-01) -
Commentary: A novel signature of 23 immunity related gene pairs is prognostic of cutaneous melanoma
by: Ruihuan Shen, et al.
Published: (2023-06-01) -
Core immune cell infiltration signatures identify molecular subtypes and promote precise checkpoint immunotherapy in cutaneous melanoma
by: Zheng Zhu, et al.
Published: (2022-08-01) -
The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature
by: Sitong Zhou, et al.
Published: (2021-10-01)